文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

会议报告:CEPI关于裂谷热流行病学与建模以支持人用疫苗开发的研讨会,内罗毕,2024年6月4-5日

Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4-5 June 2024.
PubMed 文献 · Vaccine · 2025-03-18

裂谷热是导致人畜共患流行的人兽共患病毒病,目前无人用疫苗获批。2024年6月CEPI在内罗毕召开研讨会,讨论裂谷热流行病学、建模优先事项及人用疫苗开发相关差距,提出五项关键优先事项。

要点

  • 需超越疫情视角,更好描述裂谷热复杂的「同一健康」流行病学及疫情间病毒持续存在。
  • 流行病学建模对研究、预测和规划至关重要,但需要准确且有代表性的数据。
  • 需要新型、改进且可及的诊断与血清学检测,以支持流行病学和病例定义。

核心结论

  • 研讨会参与者提出五项关键优先事项:超越疫情视角、更好的数据用于更好的模型、新型改进可及的诊断与血清学检测、明确人用疫苗的使用场景与监管路径及实施策略、以人为中心的方法。
  • 参与者欢迎对裂谷热流行病学和建模的重新关注,并表达对持续多学科合作以支持人用裂谷热疫苗研发使能科学的热情。

研究设计与样本

  • 2024年6月,流行病防范创新联盟(CEPI)在肯尼亚内罗毕召开为期两天的研讨会,讨论裂谷热流行病学、建模优先事项及与人用裂谷热疫苗开发相关的具体差距。
  • 研讨会包括来自多个裂谷热流行国家的代表、关键全球合作方和国际卫生组织。

主要发现

  • 裂谷热是导致人畜共患流行的人兽共患病毒病,造成重大健康和社会经济后果。
  • 目前无人用裂谷热疫苗获批,但若干候选疫苗在早期开发中显示出前景。
  • 现有裂谷热流行病学数据差距和预测裂谷热疫情风险的挑战使疗效研究规划复杂化,使有前景候选疫苗的许可路径不明确。

关键数值与推荐

  • 优先事项1:超越疫情视角,需更好描述裂谷热复杂的「同一健康」流行病学并理解病毒在疫情间的持续存在。
  • 优先事项2:更好的数据用于更好的模型,流行病学建模对研究、预测和规划至关重要,但需要准确且有代表性的数据。
  • 优先事项3:需要新型、改进且可及的诊断与血清学检测,以支持流行病学和病例定义。
  • 优先事项4:明确人用疫苗的使用场景、监管路径和实施策略,将促进裂谷热疫苗的许可和有效使用。
  • 优先事项5:以人为中心的方法,社区参与及社会和行为科学家的参与是人用疫苗研发和实施成功的关键。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rift Valley fever (RVF) is a zoonotic viral disease that causes epidemics and epizootics among humans and livestock, resulting in substantial health and socioeconomic consequences. Currently, there are no RVF vaccines licensed for humans, but several candidates show promise in early-stage development. Existing gaps in RVF epidemiological data and challenges associated with predicting RVF outbreak risk complicate the planning of efficacy studies, making the pathway to licensure for promising candidates unclear. In June 2024, the Coalition for Epidemic Preparedness Innovations (CEPI) convened a two-day workshop in Nairobi, Kenya, to discuss RVF epidemiology, modeling priorities, and specific gaps relevant to human RVF vaccine development. The workshop included representatives from multiple RVF-endemic countries, key global collaborators, and international health organizations. Workshop participants identified five key priorities: (1) Looking beyond outbreaks: There is a need to better characterize the complex One Health epidemiology of RVF and understand interepidemic persistence of the virus; (2) Better data for better models: Epidemiological modeling is crucial for research, prediction, and planning, but it requires accurate and representative data; (3) New, improved and accessible diagnostics and serological assays: These are needed to inform epidemiology and case definitions, without which RVF research will continue to suffer due to paucity of data and challenges in determining infection and exposure; (4) Defining use cases, regulatory pathways, and implementation strategies for human vaccines: Clarity on these topics will facilitate licensure and effective use of RVF vaccines; and (5) People-centered approaches: Community engagement and involvement of social and behavioral scientists are key to the success of human vaccine research and development and implementation, particularly as the virus impacts livestock and livelihoods. Workshop participants welcomed a renewed focus for RVF epidemiology and modeling, and expressed enthusiasm for continued multidisciplinary collaborations to support enabling sciences for human RVF vaccine research and development.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gharpure R, Vegvari C, Abdissa A, et al. Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4-5 June 2024. Vaccine. 2025. PMID: 40101455. doi:10.1016/j.vaccine.2025.126860

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。